---
title: "上海南方模式生物科技股份有限公司 (688265.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688265.SH.md"
symbol: "688265.SH"
name: "上海南方模式生物科技股份有限公司"
industry: "生命科学工具与服务"
---

# 上海南方模式生物科技股份有限公司 (688265.SH)

| Item | Detail |
|------|--------|
| Industry | 生命科学工具与服务 |
| Location | 沪深市场 |
| Website | [www.modelorg.com](https://www.modelorg.com) |

## Company Profile

公司成立于 2000 年 9 月，始终以编辑基因、解码生命为己任，专注于模式生物领域，专业从事遗传修饰动物模型的研发、饲养繁育和分析检测，致力于为全球高校、科研院所、医院、制药企业提供全面、便捷、专业的模式生物技术服务和模型资源。公司主要从事基因修饰动物模型的研发、生产、销售及相关技术服务。公司产品及服务：定制化模型、标准化模型、模型繁育、药效评价及表型分析、饲养服务、其他模式生物技术服务。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-14T04:30:09.000Z

**Overall: B (0.36)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 10 / 27 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 15.32% |  |
| Net Profit YoY | 328.93% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.10 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.58B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 419.12M |  |


**Multi Score**: B

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 2.88% | C |
| Profit Margin | 11.56% | B |
| Gross Margin | 55.86% | B |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 15.32% | B |
| Net Profit YoY | 328.93% | A |
| Total Assets YoY | 0.90% | C |
| Net Assets YoY | 2.54% | C |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 864.90% | B |
| OCF YoY | 15.32% | B |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.22 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 10.38% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 上海南方模式生物科技股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "2.88%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "11.56%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "55.86%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "15.32%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "328.93%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.90%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "2.54%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "864.90%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "15.32%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.22",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "10.38%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 药明康德 (SH.603259) | A | A | C | B | B | B |
| 02 | 康龙化成 (SZ.300759) | B | B | C | C | B | B |
| 03 | 皓元医药 (SH.688131) | B | A | C | C | B | B |
| 04 | 成都先导 (SH.688222) | B | B | D | B | B | B |
| 05 | 赛分科技 (SH.688758) | C | B | E | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 73.92 | 12/27 | 135.06 | 113.19 | 71.90 |
| PB | 2.10 | 4/27 | 2.25 | 1.87 | 1.28 |
| PS (TTM) | 8.55 | 14/27 | 9.33 | 7.61 | 5.70 |
| Dividend Yield | 0.00% | - | 0.49% | 0.47% | 0.44% |

## References

- [Company Overview](https://longbridge.com/en/quote/688265.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688265.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688265.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.